Yan et al. reported that the proliferation and angiogenesis of RCC cells both in vitro and in vivo are suppressed using the KDM4D-IN-1 inhibitor, which successfully inhibits the demethylation activity of JMJD2D [107]. This evidence concerns the gene KDM4D and renal cell carcinoma.